JOHN DAVID HARRIS Insider Profile
4 Followers
JOHN DAVID HARRIS, VP and GM Cell Therapy at Cerenome, holds 0.00 shares in Cerenome (Ticker: CNSY). Most recently, JOHN DAVID HARRIS Bought 2,500 shares of Cerenome on Aug 11, 2016 for an estimated value of $5.08K.
JOHN DAVID HARRIS's Trading History
| CNSYCerenome | Aug 11, 2016 | VP and GM Cell Therapy | Informative Buy | 5.08K | $0.00 | |
You May Also Like
JOHN DAVID HARRIS insider profile FAQ
What is the percentage of profitable transactions made by JOHN DAVID HARRIS?
The percentage of profitable transactions made by JOHN DAVID HARRIS is 0%.
What is the average return per transaction made by JOHN DAVID HARRIS?
The average return per transaction made by JOHN DAVID HARRIS is -72.20%.
What stocks does JOHN DAVID HARRIS hold?
JOHN DAVID HARRIS holds: CNSY stocks.
What was JOHN DAVID HARRIS’s latest transaction?
JOHN DAVID HARRIS’s latest transaction was an Informative Buy of $5.08K.
What was JOHN DAVID HARRIS's most profitable transaction?
JOHN DAVID HARRIS’s most profitable transaction was an Informative Buy of CNSY stock on May 16, 2016. The return on the trade was -62.40%.
What is JOHN DAVID HARRIS's role in Cerenome?
JOHN DAVID HARRIS's role in Cerenome is VP and GM Cell Therapy.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
